Header Logo

Connection

ANAIS MALPICA to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications ANAIS MALPICA has written about Biomarkers, Tumor.
ANAIS MALPICA
Connection Strength
1.232
Biomarkers, Tumor
  1. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Int J Gynecol Pathol. 2016 Sep; 35(5):410-8.
    View in: PubMed
    Score: 0.143
  2. Use of immunohistochemistry in the diagnosis of miscellaneous and metastatic tumors of the uterine corpus and cervix. Semin Diagn Pathol. 2014 May; 31(3):233-57.
    View in: PubMed
    Score: 0.121
  3. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol. 2010 Mar; 34(3):393-400.
    View in: PubMed
    Score: 0.091
  4. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol. 2007 May; 31(5):774-82.
    View in: PubMed
    Score: 0.075
  5. Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review. Int J Gynecol Pathol. 2003 Apr; 22(2):136-40.
    View in: PubMed
    Score: 0.056
  6. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior. Am J Surg Pathol. 2020 04; 44(4):429-443.
    View in: PubMed
    Score: 0.046
  7. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S40-S63.
    View in: PubMed
    Score: 0.042
  8. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases. Am J Surg Pathol. 2016 May; 40(5):577-86.
    View in: PubMed
    Score: 0.035
  9. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol. 2013 Nov; 37(11):1635-47.
    View in: PubMed
    Score: 0.029
  10. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One. 2013; 8(10):e75899.
    View in: PubMed
    Score: 0.029
  11. Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T1?2N0M0 breast cancer. Pol J Pathol. 2013 Apr; 64(1):1-8.
    View in: PubMed
    Score: 0.028
  12. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Am J Surg Pathol. 2012 Jul; 36(7):955-63.
    View in: PubMed
    Score: 0.027
  13. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012 Jan; 36(1):117-27.
    View in: PubMed
    Score: 0.026
  14. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma. Mod Pathol. 2011 Sep; 24(9):1262-71.
    View in: PubMed
    Score: 0.025
  15. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3. J Clin Pathol. 2011 Apr; 64(4):303-7.
    View in: PubMed
    Score: 0.025
  16. Expression of the retinoblastoma-related gene Rb2/p130 in the pathogenesis of serous carcinoma of the ovary. Appl Immunohistochem Mol Morphol. 2010 Dec; 18(6):509-11.
    View in: PubMed
    Score: 0.024
  17. High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases. Anal Cell Pathol (Amst). 2010; 33(5):245-55.
    View in: PubMed
    Score: 0.023
  18. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Int J Gynecol Pathol. 2009 Jul; 28(4):316-21.
    View in: PubMed
    Score: 0.022
  19. Primary retroperitoneal mucinous tumors: a clinicopathologic study of 18 cases. Am J Surg Pathol. 2009 Apr; 33(4):526-33.
    View in: PubMed
    Score: 0.021
  20. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol. 2009 Apr; 33(4):633-8.
    View in: PubMed
    Score: 0.021
  21. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium. Int J Gynecol Pathol. 2009 Mar; 28(2):142-7.
    View in: PubMed
    Score: 0.021
  22. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol. 2008 Feb; 32(2):219-28.
    View in: PubMed
    Score: 0.020
  23. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Mod Pathol. 2008 Apr; 21(4):485-90.
    View in: PubMed
    Score: 0.020
  24. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007 Nov; 31(11):1759-63.
    View in: PubMed
    Score: 0.019
  25. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006 Feb; 30(2):177-84.
    View in: PubMed
    Score: 0.017
  26. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006 Jan; 25(1):52-8.
    View in: PubMed
    Score: 0.017
  27. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol. 2005 Aug; 29(8):1034-41.
    View in: PubMed
    Score: 0.017
  28. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004 Nov; 28(11):1499-505.
    View in: PubMed
    Score: 0.016
  29. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol. 2003 Oct; 7(5):300-5.
    View in: PubMed
    Score: 0.015
  30. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol. 2003 Apr; 22(2):162-7.
    View in: PubMed
    Score: 0.014
  31. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Am J Surg Pathol. 2022 01 01; 46(1):105-117.
    View in: PubMed
    Score: 0.013
  32. Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract. Int J Gynecol Pathol. 2021 Nov 01; 40(6):523-532.
    View in: PubMed
    Score: 0.013
  33. Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer Discov. 2021 11; 11(11):2738-2747.
    View in: PubMed
    Score: 0.013
  34. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases. Am J Surg Pathol. 2021 03 01; 45(3):304-316.
    View in: PubMed
    Score: 0.012
  35. Yolk Sac Tumor in Extragonadal Pelvic Sites: Still a Diagnostic Challenge. Am J Surg Pathol. 2017 01; 41(1):1-11.
    View in: PubMed
    Score: 0.009
  36. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56.
    View in: PubMed
    Score: 0.009
  37. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015 Dec; 28(12):1613-20.
    View in: PubMed
    Score: 0.008
  38. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994 Apr; 25(4):390-5.
    View in: PubMed
    Score: 0.008
  39. Co-existence of a large ovarian hemangioma and microscopic dysgerminoma in a 10-year old child. Turk Patoloji Derg. 2014; 30(3):210-4.
    View in: PubMed
    Score: 0.007
  40. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am J Surg Pathol. 2011 Jun; 35(6):904-12.
    View in: PubMed
    Score: 0.006
  41. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am J Obstet Gynecol. 2011 Apr; 204(4):357.e1-12.
    View in: PubMed
    Score: 0.006
  42. BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol. 2010 Oct; 177(4):1611-7.
    View in: PubMed
    Score: 0.006
  43. Florid cystic endosalpingiosis presenting as an obstructive colon mass mimicking malignancy: case report and literature review. J Gastrointest Cancer. 2007; 38(2-4):83-6.
    View in: PubMed
    Score: 0.005
  44. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis. Int J Gynecol Pathol. 2007 Oct; 26(4):404-9.
    View in: PubMed
    Score: 0.005
  45. Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3. Clin Cancer Res. 2005 Jan 01; 11(1):390-6.
    View in: PubMed
    Score: 0.004
  46. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol. 2003 Jun; 16(6):584-90.
    View in: PubMed
    Score: 0.004
  47. Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 2002 Nov; 26(11):1450-7.
    View in: PubMed
    Score: 0.003
  48. Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature. Int J Gynecol Pathol. 1999 Oct; 18(4):366-73.
    View in: PubMed
    Score: 0.003
  49. Vulvar intraepithelial neoplasia and vulvar cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):295-324.
    View in: PubMed
    Score: 0.002
  50. Cervical intraepithelial neoplasia and cervical cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):347-410.
    View in: PubMed
    Score: 0.002
  51. Endometrial hyperplasia and endometrial cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):411-56.
    View in: PubMed
    Score: 0.002
  52. Uterine sarcoma. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):457-73.
    View in: PubMed
    Score: 0.002
  53. Ovarian intraepithelial neoplasia and ovarian cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):475-543.
    View in: PubMed
    Score: 0.002
  54. Gestational trophoblastic disease. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):545-71.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.